Pharmaceutical Products - Successive Deliveries Of Dichlorku Radu - 223 And Oxodotreotide Of The Lu - 177 Luttet. Task 1 - Successive Deliveries Of Dichlorku Radu -223, Used To Treat The Prostate Cancer Resistant To The Nuclear Medicine Department,,Task 2 - Successive Delivery Of The Lu -177 Oxodotreotide, Used To Treat Neuroendocrine Cancers Of The Digestive System To The Nuclear Medicine Department
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.